These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 401712

  • 21. The clinical evaluation of an oral antidiabetic drug.
    Müller R.
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Glibenclamide, a new oral antidiabetic].
    Edlén A.
    Lakartidningen; 1972 Jan 19; 69(4):342-3. PubMed ID: 4622487
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Improvement in motor nerve conduction following treatment in newly diagnosed diabetics.
    Ward JD.
    Adv Metab Disord; 1973 Jan 19; 2():Suppl 2:569-73. PubMed ID: 4720388
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
    Heine P, Kewitz H, Wiegboldt KA.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Jan 19; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
    [No Abstract] [Full Text] [Related]

  • 33. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V, Theodorides C, Palamidou F, Frissiras S, Berdousi H, Kattamis C.
    J Pediatr Endocrinol Metab; 1998 Jan 19; 11 Suppl 3():871-8. PubMed ID: 10091160
    [Abstract] [Full Text] [Related]

  • 34. [Differential therapy using oral antidiabetics].
    Mehnert H.
    Internist (Berl); 1971 Nov 19; 12(11):468-75. PubMed ID: 4943878
    [No Abstract] [Full Text] [Related]

  • 35. [Mechanism of action of gliquidone (author's transl)].
    Zilker T, Ermler R, Henderkott U, Bottermann P.
    Dtsch Med Wochenschr; 1975 Aug 29; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.
    Pfeiffer EF, Raptis S.
    Diabetologia; 1972 Feb 29; 8(1):41-7. PubMed ID: 4623790
    [No Abstract] [Full Text] [Related]

  • 38. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K, Steen B, Svanborg A.
    Lakartidningen; 1969 Nov 05; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E, Beyer J, Schöffling K.
    Dtsch Med Wochenschr; 1974 Mar 01; 99(9):385-8. PubMed ID: 4208186
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.